Latest news
Loading news…
Ikena Oncology
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Boston, Massachusetts, United States Founded 2016 51-100 employees For Profit
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Ikena Oncology was acquired by ImageneBio in 2024.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
65
Ticker
IKNA
NASDAQ
Patents
34
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- IKNA
- Exchange
- NASDAQ
- IPO date
- Mar 26, 2021
- Raised at IPO
- $125M
- Valuation at IPO
- $482M
- Valuation range
- $500M to $1B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 18
- Patents granted
- 34
- Trademarks
- 2
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $142K
Company Info
- Founded
- 2016
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 95
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded
- Exit date
- Mar 26, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0.4
- Trend (30d)
- 1.5
- Trend (90d)
- -0.1
- Last leadership hire
- Feb 21, 2024
- Last layoff mention
- May 28, 2024
Acquisitions by Ikena Oncology
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Ikena Oncology
Associate Director, Strategic Pipeline Planning
Senior Vice President, Translational Research and Early Development
Chief Financial Officer and Head of Corporate Development
Co-Founder & Vice President Of Drug Discovery
Chief Development Officer
65
professional contacts at Ikena Oncology
Contact execs at Ikena Oncology →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ikena Oncology
Loading news…
FAQs about Ikena Oncology
People who checked this page also checked these
Sectors Ikena Oncology invests & acquires in
Browse the full Acquirezy directory.